{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:02:41Z","timestamp":1791216161025,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Occult breast cancer (OBC) is characterized as a breast carcinoma that remains undetectable through imaging modalities. OBC is a rare condition, accounting for only 0.3%-1.0% of all breast cancers, and is often clinically associated with metastases to the axillary and cervical lymph nodes. Metastasis of occult primary breast cancer to the cervix, stomach, or rectum is exceptionally rare. Here, we report the case of a 64-year-old woman presenting with clinical symptoms of urinary urgency, frequency, severe rectal discomfort, and altered stool morphology. Ga68-positron emission tomography-computed tomography (Ga68-FAPI PET\/CT) identified diffuse tumor-associated fibrin expression within the gastric wall, while 18F-fluorodeoxyglucose PET\/CT (18F-FDG PET\/CT) revealed marked annular thickening of the rectal wall. Notably, imaging evaluations, including mammography, breast ultrasonography, and 18F-FDG PET\/CT, failed to detect primary breast lesions. Histopathological examination and immunohistochemical analysis of biopsied cervical, gastric, and rectal lesions confirmed the diagnosis of OBC. Following six months of treatment with letrozole (1mg\/day) in combination with dalpiciclib the patient demonstrated significant symptomatic relief, with remarkable reduction in the lesions located in the cervix, stomach, and rectum. This case represents the first documented instance of occult primary breast cancer with simultaneous metastases to the cervix, stomach, and rectum.<\/jats:p>","DOI":"10.3389\/fonc.2025.1598840","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:12:48Z","timestamp":1757304768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Synchronous cervical, gastric and rectal metastases in occult breast cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Ruoying","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Hyuna","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population- based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Shaoyuan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-018-4898-4","article-title":"Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes","volume":"172","author":"Mitsuo","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_329_17","article-title":"Occult breast cancer in a female with benign lesions","volume":"15","author":"Francesca","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.21037\/cco.2019.01.06","article-title":"Occult breast cancer: The uncommon presentation of a common disease","volume":"8","author":"Hyuna","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000335449","article-title":"Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis","volume":"5","author":"Jue","year":"2012","journal-title":"Case Rep Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000484346","article-title":"Occult breast carcinoma presenting as scalp metastasis","volume":"10","author":"Ricardo","year":"2017","journal-title":"Case Rep Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"bcr2017223542","DOI":"10.1136\/bcr-2017-223542","article-title":"Orbital metastasis from an occult breast carcinoma (T0, N1, M1)","volume":"2018","author":"Rita","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e8529","DOI":"10.1097\/MD.0000000000008529","article-title":"Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: a case report","volume":"96","author":"Lulu","year":"2017","journal-title":"Medicine"},{"key":"B10","article-title":"Diagnosis and treatment of occult breast cancer: report of 23 cases","volume":"32","author":"Ying","year":"2010","journal-title":"Chin J Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2008.11.015","article-title":"Case report: diffuse splenic metastasis of occult breast cancer with incompatible blood group antigenic determinants","volume":"111","author":"Hyuna","year":"2009","journal-title":"Acta Histochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2306","article-title":"Unique presentation of occult breast cancer with uterine cervix metastasis","volume":"7","author":"Emanuela","year":"2019","journal-title":"Clin Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Hyuna","year":"2012","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"m4050","DOI":"10.1136\/bmj.m4050","article-title":"Cancer of unknown primary","volume":"371","author":"Hyuna","year":"2020","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12282-022-01348-y","article-title":"Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: A study based on the Japanese National Clinical Database-Breast Cancer Registry","volume":"29","author":"Mitsuo","year":"2022","journal-title":"Breast Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2012.08.022","article-title":"Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer","volume":"38","author":"He","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-001-0425-6","article-title":"Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases","volume":"8","author":"Vlastos","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.11.008","article-title":"The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance,epidemiology, and End Results dataset","volume":"45","author":"Qian","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF02239526","article-title":"Gastric and colonic metastases from breast cancer","volume":"17","author":"Hyuna","year":"1972","journal-title":"Am J Dig Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e52765","DOI":"10.7759\/cureus.52765","article-title":"Therapeutic effects of CDK4\/6 inhibitors in gastric and colonic metastases from breast cancer: A case report","volume":"16","author":"Sasaki","year":"2024","journal-title":"Cureus"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.08.007","article-title":"Wide metastatic spreading in infiltrating lobular carcinomaof the breast","volume":"40","author":"Ferlicot","year":"2004","journal-title":"Eur J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.07.006","article-title":"Isolated cervical metastasis of breast cancer: a case report and review of the literature","volume":"95","author":"Hyuna","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B23","article-title":"Breast cancer metastasising to the uterine cervix","volume":"68","author":"Hyuna","year":"1999","journal-title":"Ulster Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0301-2115(98)00268-1","article-title":"Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy","volume":"83","author":"Piura","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2017.12.005","article-title":"Comparison of contrast-enhanced mammography and contrastenhanced breast MR imaging","volume":"26","author":"Hyuna","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2013.06.020","article-title":"Occult primary breast cancer at a comprehensive cancer center","volume":"185","author":"Hyuna","year":"2013","journal-title":"J Surg Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1106890","article-title":"Case report: Uncommon multiple metastases from occult breast cancer revealed by 68Ga-DOTATATE PET\/CT","volume":"13","author":"Hu","year":"2023","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"11","author":"Gradishar","year":"2013","journal-title":"JNatl Compr Canc Netw"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1051232","article-title":"Best treatment options for occult breast cancer: A meta-analysis","volume":"13","author":"Hyuna","year":"2023","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5928-x","article-title":"Factors influencing management and outcome in patients with occult breastcancer with axillary lymph node involvement: Analysis of the national cancer database","volume":"24","author":"Hyuna","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08345-5","article-title":"ASO author reflections: SLNB with RT may be sufficientin occult breast cancer after NAC","volume":"27","author":"Hyuna","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08939-z","article-title":"Avoiding an axillary lymph node dissection:The benefit of neoadjuvant chemotherapy for occult primary breast cancer","volume":"27","author":"Hyuna","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolatedtumor cells and theoutcome of breast cancer","volume":"36","author":"Hyuna","year":"2009","journal-title":"NEnglJMed"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-1264-0","article-title":"Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature","volume":"281","author":"Hyuna","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e8200","DOI":"10.1097\/MD.0000000000008200","article-title":"Application of neoadjuvant chemotherapy in occult breast cancer: five case reports","volume":"96","author":"Hyuna","year":"2017","journal-title":"Medicine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.19401\/j.cnki.1007-3639.2023.12.004","article-title":"Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)","volume":"33","author":"Hyuna","year":"2023","journal-title":"China Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00172-9","article-title":"Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"24","author":"Hyuna","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598840\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:16:50Z","timestamp":1757305010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598840\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":37,"alternative-id":["10.3389\/fonc.2025.1598840"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1598840","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"article-number":"1598840"}}